El Salvador vs Singapore: Number of deaths from cardiovascular diseases
El Salvador
9,001 deaths
in 2021
Singapore
9,690 deaths
in 2021
El Salvador rank
123rd
Singapore rank
120th
Number of deaths from cardiovascular diseases over time
- El Salvador
- Singapore
How they compare
Singapore currently reports 9,690 deaths against 9,001 deaths in El Salvador, a difference of 689 deaths.
That makes Singapore's figure about 1.1 times El Salvador's.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Singapore ahead.
El Salvador ranks 123rd and Singapore ranks 120th of 194 countries.
El Salvador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | El Salvador | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6,391 deaths | 6,027 deaths | 363.89 deaths | El Salvador |
| 2010s | 8,276 deaths | 6,970 deaths | 1,305 deaths | El Salvador |
| 2020s | 9,201 deaths | 9,188 deaths | 12.87 deaths | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of deaths from cardiovascular diseases, El Salvador or Singapore?
- Singapore, at 9,690 deaths against 9,001 deaths in El Salvador as of 2021.
- What is the difference in number of deaths from cardiovascular diseases between El Salvador and Singapore?
- 689 deaths, with Singapore ahead.
- How many years of comparable data are there for El Salvador and Singapore?
- 22 years are reported by both, from 2000 to 2021.
- How do El Salvador and Singapore rank globally for number of deaths from cardiovascular diseases?
- El Salvador ranks 123rd and Singapore ranks 120th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Number of deaths from cardiovascular diseases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from cardiovascular diseases in both sexes.